Bupivacaine administered via a CIC FNB
+ Local Infiltration (1210 mg total dose);
Cmax = 1760 ng/mL5
Your request has been received.
We will send you more information as it becomes available.
days to go: ASP+6% CMS reimbursement for proven non-opioids used in all outpatient surgical settings is coming January 1, 2025.
At both maximum doses of EXPAREL (266 mg for infiltration and 133 mg for interscalene brachial plexus nerve block), the plasma levels of bupivacaine remain below toxicity thresholds2-5
EXPAREL Dosing & Procedure
Bupivacaine administered via a CIC FNB
+ Local Infiltration (1210 mg total dose);
Cmax = 1760 ng/mL5
Cmax of plasma bupivacaine concentration (ng/mL)
Bupivacaine concentrations were evaluated in maternal plasma and transfer into breast milk in women undergoing EXPAREL infiltration in the transversus abdominis plane after cesarean birth.
Results showed:
In addition, concentrations of bupivacaine in breast milk following continuous epidural infusion for up to 5 days have been found to be minimal14,15
ASP, average sales price; CMS, Centers for Medicare and Medicaid Services.
EXPAREL® (bupivacaine liposome injectable suspension) is indicated to produce postsurgical local analgesia via infiltration in patients aged 6 years and older and regional analgesia in adults via an interscalene brachial plexus nerve block, sciatic nerve block in the popliteal fossa, and an adductor canal block. Safety and efficacy have not been established in other nerve blocks.
Please refer to full Prescribing Information.
EXPAREL® (bupivacaine liposome injectable suspension) is indicated to produce postsurgical local analgesia via infiltration
This website uses cookies to give you a better browsing experience. By clicking the "Allow all cookies" button, you agree to our use of cookies. For additional information, see our Cookie Notice.